InSyte Bio

Nearly 1 in 3 cancer surgeries leave cells behind, doubling the rate that cancer returns. InSyte Bio’s mission is to eliminate the recurrence by ensuring removal of all cancer cells during surgery. We have developed a surgical imaging system that can detect cancer cells 10,000 times more precisely than existing solutions in real-time, during surgery, enabling surgeons and oncologists to effectively combat the spread of cancer. The key to our approach is an ultra-miniaturized molecular imager directly integrated into virtually any surgical instrument - transforming the instrument itself into robotic instruments - into a highly sensitive imager seamlessly operating in the complex, small minimally invasive cavities common to modern cancer surgeries.

Website

https://insyte.bio

External link for InSyte Bio

Industry

Biotechnology Research

Company size

2-10 employees

Headquarters

San Francisco, California

Type

Privately Held

Founded

2023

Specialties

biotechnology, imaging, intraoperative imaging, cancer, cancer surgery, integrated circuits, and optics